0,981  0,003  CYP1A2 inhibitor
0,961  0,001  NOS2 expression inhibitor
0,930  0,001  CTGF expression inhibitor
0,929  0,002  AR expression inhibitor
0,909  0,004  CYP1A2 substrate
0,861  0,002  Monophenol monooxygenase inhibitor
0,852  0,004  Aldehyde oxidase inhibitor
0,845  0,002  Melanin inhibitor
0,840  0,003  NOS3 expression inhibitor
0,831  0,004  Lipoxygenase inhibitor
0,828  0,004  Chemopreventive
0,825  0,004  Antioxidant
0,826  0,014  Apoptosis agonist
0,812  0,005  15-Lipoxygenase inhibitor
0,809  0,003  UGT1A1 substrate
0,808  0,002  UGT1A3 substrate
0,804  0,003  Hypoxia-inducible factor 1 alpha inhibitor
0,805  0,007  CYP2C9 substrate
0,800  0,013  Transcription factor NF kappa B inhibitor
0,773  0,004  Cardioprotectant
0,767  0,004  Free radical scavenger
0,768  0,006  Chemoprotective
0,763  0,004  CYP2C19 inhibitor
0,762  0,008  Carcinogenic
0,752  0,004  MAO inhibitor
0,746  0,005  CYP2C19 substrate
0,740  0,005  Antineoplastic (melanoma)
0,745  0,013  Antineoplastic (lung cancer)
0,730  0,003  NOS3 expression enhancer
0,730  0,004  Skin whitener
0,730  0,005  UGT1A9 substrate
0,722  0,007  Cytostatic
0,716  0,012  Antileukemic
0,714  0,019  Antineoplastic (breast cancer)
0,692  0,005  Caspase 3 stimulant
0,689  0,005  Antineoplastic (glioma)
0,703  0,023  Caspase 9 stimulant
0,674  0,007  Proliferative diseases treatment
0,657  0,005  Antiprotozoal (Leishmania)
0,662  0,010  Mutagenic
0,650  0,003  Antihypotensive
0,651  0,006  Antimutagenic
0,657  0,022  CYP3A4 substrate
0,652  0,018  Antineoplastic (colorectal cancer)
0,639  0,010  Spasmolytic
0,645  0,018  Antineoplastic (colon cancer)
0,624  0,008  UGT1A6 substrate
0,613  0,006  UDP-glucuronosyltransferase substrate
0,640  0,043  Antiinflammatory
0,599  0,002  Alcohol dehydrogenase inhibitor
0,600  0,008  DNA damaging
0,601  0,010  CYP2C9 inhibitor
0,634  0,046  Alpha-glucosidase inhibitor
0,588  0,003  Xanthine oxidase inhibitor
0,595  0,014  12-Lipoxygenase inhibitor
0,589  0,010  Nitric oxide antagonist
0,583  0,012  Antiosteoporotic
0,575  0,004  MAO A inhibitor
0,584  0,016  Bone diseases treatment
0,583  0,015  Antineoplastic (cervical cancer)
0,570  0,005  Sulfotransferase substrate
0,582  0,017  Antineoplastic (ovarian cancer)
0,565  0,003  Estrogen receptor alpha antagonist
0,575  0,016  Radioprotector
0,584  0,028  TNF expression inhibitor
0,574  0,021  Prostate cancer treatment
0,571  0,019  Antihypercholesterolemic
0,556  0,004  Lipid peroxidase inhibitor
0,562  0,013  Antiparasitic
0,562  0,013  Apoptosis antagonist
0,549  0,003  UGT2B15 substrate
0,546  0,004  Breast cancer-resistant protein inhibitor
0,549  0,008  Antihelmintic
0,545  0,012  Hypoglycemic
0,533  0,007  Carcinogenic, group 3
0,527  0,010  Vasodilator
0,533  0,015  Antineoplastic (brain cancer)
0,524  0,008  Peroxidase inhibitor
0,534  0,019  Histamine release inhibitor
0,525  0,012  Antiprotozoal (Trypanosoma)
0,522  0,011  Antineoplastic (glioblastoma multiforme)
0,522  0,013  Vasodilator, coronary
0,518  0,010  Antihypertriglyceridemic
0,513  0,010  RNA-directed DNA polymerase inhibitor
0,513  0,020  Hepatic disorders treatment
0,498  0,009  Pyruvate kinase inhibitor
0,489  0,005  MAO B inhibitor
0,511  0,029  5 Hydroxytryptamine release inhibitor
0,515  0,036  Antibacterial
0,501  0,026  GABA C receptor rho-3 antagonist
0,469  0,005  Aldehyde dehydrogenase inhibitor
0,489  0,025  Aryl hydrocarbon receptor agonist
0,476  0,012  Antihypoxic
0,477  0,014  Vascular (periferal) disease treatment
0,470  0,008  Hepatoprotectant
0,456  0,008  Topoisomerase II inhibitor
0,465  0,018  Amyloid beta aggregation inhibitor
0,445  0,003  VEGF expression inhibitor
0,460  0,018  CYP3A4 inhibitor
0,445  0,006  Protein-tyrosine phosphatase inhibitor
0,454  0,023  Antineoplastic (non-small cell lung cancer)
0,435  0,005  Heat shock protein 90 alpha antagonist
0,454  0,033  CYP2D6 substrate
0,416  0,004  Heat shock protein 90 antagonist
0,410  0,005  Protein-tyrosine phosphatase 1B inhibitor
0,416  0,014  P-glycoprotein inhibitor
0,426  0,031  ICAM1 expression inhibitor
0,431  0,045  Ulceration
0,385  0,010  Amylase inhibitor
0,394  0,023  Antineoplastic (osteosarcoma)
0,425  0,059  Antiprotozoal
0,393  0,030  Antiamyloidogenic
0,366  0,006  Cystathionine beta-synthase inhibitor
0,354  0,002  SULT1E1 substrate
0,420  0,068  Antiparkinsonian
0,363  0,012  Bone formation stimulant
0,347  0,007  NADPH oxidase inhibitor
0,343  0,004  NAD(P)H dehydrogenase (quinone) inhibitor
0,343  0,005  Histidine decarboxylase inhibitor
0,342  0,005  Dementia treatment
0,420  0,084  Alzheimer's disease treatment
0,373  0,037  UGT2B4 substrate
0,339  0,005  Vascular dementia treatment
0,349  0,015  Tubulin antagonist
0,379  0,046  Antiischemic
0,372  0,040  Cytotoxic
0,344  0,014  Genotoxic
0,334  0,007  Antihemorrhagic
0,360  0,033  Antineoplastic (renal cancer)
0,329  0,006  Topoisomerase II alpha inhibitor
0,322  0,004  CF transmembrane conductance regulator agonist
0,323  0,005  Estrogen receptor beta antagonist
0,322  0,005  Estrogen antagonist
0,341  0,027  Antineoplastic (bladder cancer)
0,368  0,056  Streptokinase A inhibitor
0,355  0,050  Antineoplastic (pancreatic cancer)
0,314  0,012  Acetylcholinesterase inhibitor
0,306  0,004  Papain-like protease (SARS coronavirus) inhibitor
0,320  0,020  MAP-kinase-activated kinase 5 inhibitor
0,333  0,034  Antineoplastic (lymphocytic leukemia)
0,302  0,010  5-Lipoxygenase inhibitor
0,297  0,006  Carbonic anhydrase XIII inhibitor
0,298  0,010  Antiprotozoal (Coccidial)
0,300  0,013  Antidiarrheal
0,291  0,005  Estrogen agonist
0,305  0,022  Pneumotoxic
0,283  0,003  Xanthine dehydrogenase inhibitor
0,292  0,014  Antineoplastic (bone cancer)
0,322  0,045  Transcription factor STAT inhibitor
0,308  0,031  Platelet adhesion inhibitor
0,318  0,044  Antineoplastic (liver cancer)
0,316  0,046  Antidiabetic symptomatic
0,331  0,067  Antifungal
0,266  0,005  Electron transport complex I inhibitor
0,265  0,005  Postmenopausal disorders treatment
0,282  0,024  CYP2B6 inhibitor
0,259  0,003  DOPA decarboxylase inhibitor
0,296  0,044  Antineoplastic (sarcoma)
0,256  0,005  Antihelmintic (Trematoda)
0,268  0,020  Histone acetyltransferase inhibitor
0,250  0,004  Carbonic anhydrase VII inhibitor
0,295  0,055  Tumour necrosis factor alpha release inhibitor
0,255  0,016  Topoisomerase I inhibitor
0,268  0,030  Mcl-1 antagonist
0,295  0,058  Antipyretic
0,270  0,034  Antialcoholic
0,244  0,009  Contraceptive female
0,286  0,051  Interleukin antagonist
0,236  0,003  Fatty acid synthase inhibitor
0,257  0,027  Cholinergic
0,259  0,029  Contraceptive
0,264  0,036  UGT2B7 substrate
0,274  0,051  Antimitotic
0,258  0,039  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,251  0,032  Amyloid beta precursor protein antagonist
0,236  0,022  Insulin secretagoues
0,230  0,018  Gout treatment
0,242  0,031  Antiseptic
0,219  0,007  Antineoplastic (uterine cancer)
0,229  0,020  SULT1A3 substrate
0,215  0,009  Creatine kinase inhibitor
0,224  0,018  Butyrylcholinesterase inhibitor
0,246  0,041  Neurotrophic factor enhancer
0,211  0,009  HIV-1 integrase (3'-Processing) inhibitor
0,211  0,009  Opioid kappa receptor antagonist
0,232  0,032  Protein kinase stimulant
0,211  0,011  Beta glucuronidase inhibitor
0,204  0,005  Interleukin 5 antagonist
0,212  0,016  SULT1A1 substrate
0,230  0,035  Antineoplastic (squamous cell carcinoma)
0,205  0,011  Gastritis treatment
0,200  0,006  Heat shock protein 70 antagonist
0,205  0,012  Photosensitizer
0,203  0,009  HIV-1 integrase (Strand Transfer) inhibitor
0,211  0,017  Antiprotozoal (Trichomonas)
0,202  0,010  Multidrug resistance-associated protein 1 inhibitor
0,330  0,138  Antidiabetic
0,330  0,138  Cyclophilin D inhibitor
0,208  0,017  Bronchodilator
0,255  0,068  Angiogenesis stimulant
0,199  0,013  Uric acid excretion stimulant
0,193  0,008  Macrophage migration inhibitory factor inhibitor
0,215  0,032  UGT2B9 substrate
0,189  0,006  Lipase inhibitor
0,186  0,005  Estradiol 17 beta-dehydrogenase inhibitor
0,261  0,084  GST M1-1 substrate
0,224  0,048  Diabetic retinopathy treatment
0,187  0,013  Antiviral (Influenza B)
0,177  0,005  Estrogen receptor beta agonist
0,180  0,008  Aldose reductase inhibitor
0,193  0,022  Endometrios treatment
0,206  0,039  Toxic, respiratory center
0,191  0,025  Interleukin 4 antagonist
0,177  0,014  Urease inhibitor
0,181  0,024  Antineoplastic antibiotic
0,205  0,049  Antineoplastic (gastric cancer)
0,180  0,024  MAP kinase kinase 4 inhibitor
0,273  0,118  Antiprotozoal (Plasmodium)
0,208  0,054  UGT1A4 substrate
0,163  0,012  Aromatase inhibitor
0,216  0,065  Antiviral (Influenza)
0,165  0,014  ABCA1 expression enhancer
0,252  0,107  Antimycobacterial
0,192  0,047  Antiviral (Influenza A)
0,161  0,019  Telomerase inhibitor
0,221  0,081  Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor
0,210  0,073  Nitric-oxide synthase stimulant
0,234  0,097  Transcription factor STAT3 inhibitor
0,154  0,018  Phosphodiesterase 4D inhibitor
0,142  0,007  Neuraminidase inhibitor
0,178  0,044  Cyclooxygenase 1 inhibitor
0,184  0,051  Interleukin 6 antagonist
0,267  0,136  Immunosuppressant
0,175  0,046  GABA C receptor rho-2 antagonist
0,161  0,034  Carcinogenic, group 2B
0,170  0,044  Neurotrophic factor
0,177  0,051  Carcinogenic, group 1
0,172  0,046  Alkaline phosphatase inhibitor
0,164  0,039  Farnesoid X receptor antagonist
0,214  0,091  Dyrk kinase inhibitor
0,174  0,056  Antineoplastic (carcinoma)
0,214  0,097  Myocardial infarction treatment
0,148  0,031  Carbonic anhydrase XV inhibitor
0,142  0,026  Toll-Like receptor 4 antagonist
0,201  0,087  Antiulcerative
0,171  0,060  Diuretic
0,117  0,007  Estrogen receptor alpha agonist
0,131  0,022  CYP2A6 inhibitor
0,197  0,088  Antineoplastic enhancer
0,166  0,059  Cyclooxygenase inhibitor
0,190  0,082  Sensitization
0,224  0,118  Antineoplastic (multiple myeloma)
0,175  0,070  Liver fibrosis treatment
0,138  0,033  Carbonic anhydrase III inhibitor
0,142  0,038  Chelator
0,150  0,047  Proteasome inhibitor
0,236  0,134  Angiogenesis inhibitor
0,158  0,058  Ca2+/calmodulin-dependent protein kinase kinase B inhibitor
0,132  0,032  Opioid antagonist
0,114  0,014  Phosphodiesterase VI inhibitor
0,173  0,073  Dual specificity phosphatase inhibitor
0,194  0,097  Teratogen
0,213  0,116  Amyotrophic lateral sclerosis treatment
0,111  0,014  Neuraminidase (influenza) inhibitor
0,137  0,045  DNA repair enzyme inhibitor
0,112  0,019  HIV-1 integrase inhibitor
0,098  0,007  Transcription factor RelA inhibitor
0,099  0,009  Opioid kappa receptor agonist
0,228  0,139  Prostaglandin dehydrogenase inhibitor
0,093  0,004  Estradiol 17 beta-dehydrogenase 1 inhibitor
0,179  0,093  Psychostimulant
0,113  0,027  Opioid delta receptor antagonist
0,133  0,048  Glutathione S-transferase substrate
0,210  0,125  Respiratory analeptic
0,110  0,026  Myeloperoxidase inhibitor
0,085  0,003  Estrogen-related receptor beta antagonist
0,168  0,088  Antirickettsial
0,124  0,044  UGT2B1 substrate
0,089  0,010  Potassium channel Kv1.3 blocker
0,114  0,035  Thioredoxin inhibitor
0,115  0,036  Androgen antagonist
0,110  0,034  Ornithine decarboxylase inhibitor
0,104  0,028  Na+ K+ transporting ATPase inhibitor
0,184  0,109  VCAM1 expression inhibitor
0,112  0,038  Protein kinase C zeta inhibitor
0,131  0,058  Alkylator
0,137  0,064  Cyclooxygenase 2 inhibitor
0,077  0,005  Retinoic acid alpha receptor agonist
0,102  0,031  Opioid mu receptor antagonist
0,081  0,013  Postcoital contraceptive
0,168  0,101  Abortion inducer
0,098  0,031  D-Ala-D-Ala ligase inhibitor
0,127  0,060  Beta amyloid protein antagonist
0,135  0,071  Antifungal enhancer
0,116  0,053  AMP-activated protein kinase stimulant
0,111  0,048  Anabolic
0,190  0,129  Cardiotonic
0,086  0,027  Beta tubulin antagonist
0,166  0,112  Insulin sensitizer
0,075  0,021  Opioid agonist
0,164  0,110  Embryotoxic
0,150  0,098  Antipruritic, non-allergic
0,062  0,010  Estradiol 17 beta-dehydrogenase 2 inhibitor
0,099  0,048  Actinic keratosis treatment
0,120  0,070  M18 aspartyl aminopeptidase inhibitor
0,117  0,068  Cholesterol synthesis inhibitor
0,075  0,027  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,116  0,069  Constipation treatment
0,081  0,034  Potassium channel large-conductance Ca-activated activator
0,086  0,041  Analgesic, opioid
0,074  0,028  Androgen agonist
0,115  0,069  Transcription factor STAT6 inhibitor
0,076  0,032  CDC25B inhibitor
0,138  0,094  Hexokinase inhibitor
0,151  0,110  Succinate dehydrogenase inhibitor
0,148  0,106  DNA methyltransferase I inhibitor
0,073  0,034  Aryl hydrocarbon receptor antagonist
0,228  0,189  Antipruritic, allergic
0,061  0,023  Antibiotic Glycopeptide-like
0,102  0,067  HDL-cholesterol increasing
0,059  0,024  Opioid mu receptor agonist
0,064  0,031  Carbonic anhydrase XII inhibitor
0,096  0,064  UGT2B11 substrate
0,084  0,052  Carbonic anhydrase VI inhibitor
0,207  0,179  GST A substrate
0,077  0,051  SULT1A2 substrate
0,088  0,067  Potassium channel (Ca-activated) activator
0,155  0,139  Antineoplastic (lymphoma)
0,111  0,096  Antibacterial (Helicobacter pylori)
0,140  0,127  LDLR expression enhancer
0,051  0,040  Alpha tubulin antagonist
0,072  0,062  Narcotic antagonist
0,024  0,015  Retinoic acid receptor agonist
0,107  0,099  Coagulant
0,157  0,149  Immunostimulant
0,077  0,071  Thioredoxin reductase inhibitor
0,066  0,060  Antibiotic
0,030  0,024  ATP citrate lysase inhibitor
0,033  0,029  Opioid delta receptor agonist
0,015  0,012  Antibiotic Tetracycline-like
0,022  0,019  Protein 30S ribosomal subunit inhibitor
0,048  0,046  Maillard reaction inhibitor
0,138  0,136  Antiviral (Hepatitis)
0,094  0,093  Antitussive
0,109  0,108  CDC-like kinase 1 inhibitor

